Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,625 USD | +11,30 % | +17,03 % | +185,84 % |
Resumen de negocios
Número de empleados: 137
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Drug Candidates
100,0
%
| 92 | 100,0 % | 90 | 100,0 % | -2,10 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rest of World
87,3
%
| 82 | 89,3 % | 79 | 87,3 % | -4,35 % |
United States
12,7
%
| 10 | 10,7 % | 11 | 12,7 % | +16,66 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 17/04/23 |
Chief Tech/Sci/R&D Officer | 49 | 01/07/15 | |
Mary Tagliaferri
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/01/15 |
Vivian Wu
IRC | Investor Relations Contact | - | 01/11/18 |
Robert Bacci
HRO | Human Resources Officer | - | 01/01/01 |
Mark Wilson
LAW | General Counsel | 52 | 01/05/02 |
Jennifer Ruddock
PRN | Corporate Officer/Principal | - | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
R. Scott Greer
BRD | Director/Board Member | 65 | 01/01/10 |
Roy A. Whitfield
BRD | Director/Board Member | 70 | 01/08/00 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Jeff Ajer
BRD | Director/Board Member | 61 | 21/09/17 |
Myriam Curet
BRD | Director/Board Member | 67 | 16/12/19 |
Diana Brainard
BRD | Director/Board Member | 53 | 11/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 183 624 232 | 181 600 254 ( 98,90 %) | 0 | 98,90 % |
Información de la empresa
Nektar Therapeutics
455 Mission Bay Boulevard South
94158, San Francisco
+415 482 5300
http://www.nektar.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Nektar Therapeutics (India) Pvt Ltd.
Nektar Therapeutics (India) Pvt Ltd. BiotechnologyHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics (India) Pvt Ltd. develops biopharmaceutical products. The private company is based in Hyderabad, India. |
Biotechnology
|
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+185,84 % | 268 M | |
+33,90 % | 704 mil M | |
+28,59 % | 577 mil M | |
-3,23 % | 348 mil M | |
+19,08 % | 327 mil M | |
+4,73 % | 288 mil M | |
+14,81 % | 234 mil M | |
+4,93 % | 198 mil M | |
-9,78 % | 194 mil M | |
-3,15 % | 147 mil M |
- Bolsa de valores
- Acciones
- Acción NKTR
- Empresa Nektar Therapeutics